Adria Cimino
Adria Cimino is a contributing Stock Market Analyst at The Motley Fool covering publicly traded companies in the healthcare, technology, and consumer goods industries. Prior to The Motley Fool, Adria covered the European stock market and U.S. stocks pre-market trading for Bloomberg News, Bloomberg TV, and Bloomberg Radio for more than a decade. Earlier in her career, she wrote about biotech, medtech, and technology companies in Boston for Mass High Tech, an American City Business Journals publication. She holds a B.A. in Mass Communications from the University of South Florida in Tampa. Fun fact: A few years ago, Adria co-founded a small publishing house specializing in women’s fiction, and published the fiction of about a dozen female authors. You’ll also find a few of her own novels, including “Paris, Rue des Martyrs,” on Amazon.
Recent Articles by Adria Cimino

10 Reasons to Buy and Hold This AI Stock Forever

My 2 Top Quantum Computing Stocks to Buy Now

2 Dividend Stocks to Double Up on Right Now

This Might Have Been Nvidia's Biggest Move Yet

Is Apple a Buy, Sell, or Hold in 2025?

Should You Worry About Palantir's Valuation?

Fantastic News for CoreWeave Shareholders

Better Growth Buy: Eli Lilly vs. Viking Therapeutics

Prediction: Nvidia Will Soar in the Second Half
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.